Annual report pursuant to Section 13 and 15(d)

STOCKHOLDERS' DEFICIT (Tables)

v3.24.2
STOCKHOLDERS' DEFICIT (Tables)
12 Months Ended
Dec. 31, 2023
Summary of outstanding warrants

A summary of the Company’s warrants activity for the years ended December 31, 2023 and 2022 is presented below:

 

December 31, 2023

 

 

December 31, 2022

 

 

Number of Warrants

 

 

Weighted
Average
Exercise
Price

 

 

Number of Warrants

 

 

Weighted
Average
Exercise
Price

 

Warrants outstanding, beginning of year

 

6,610,520

 

 

$

2.22

 

 

 

8,236,017

 

 

$

5.78

 

Granted

 

8,500,000

 

 

$

4.03

 

 

 

500,000

 

 

$

2.50

 

Exercised

 

 

 

$

 

 

 

 

 

$

 

Cancelled, forfeited and expired

 

(10,378,129

)

 

$

4.23

 

 

 

(2,125,497

)

 

$

14.38

 

Warrants outstanding, end of year

 

4,732,391

 

 

$

0.95

 

 

 

6,610,520

 

 

$

2.22

 

Warrant exercisable, end of year

 

4,732,391

 

 

$

0.95

 

 

 

6,610,520

 

 

$

2.22

 

Summary of stock option activity

A summary of the Company’s stock option activity for the years ended December 31, 2023 and 2022 is presented below:

 

 

December 31, 2023

 

 

December 31, 2022

 

 

 

Number of
Options

 

 

Weighted‑
Average
Exercise
Price

 

 

Number of
Options

 

 

Weighted‑
Average
Exercise
Price

 

Options outstanding, beginning of year

 

 

4,660,787

 

 

$

5.08

 

 

 

5,968,338

 

 

$

4.78

 

Granted or deemed issued

 

 

1,250,000

 

 

$

4.50

 

 

 

 

 

$

 

Exercised

 

 

 

 

$

 

 

 

 

 

$

 

Cancelled, forfeited and expired

 

 

(2,686,906

)

 

$

3.74

 

 

 

(1,307,551

)

 

$

3.73

 

Options outstanding, end of year

 

 

3,223,881

 

 

$

5.97

 

 

 

4,660,787

 

 

$

5.08

 

Options exercisable at end of year

 

 

2,373,881

 

 

$

6.50

 

 

 

4,645,286

 

 

$

5.10

 

Options available for future grant

 

 

2,750,000

 

 

 

 

 

 

4,000,000

 

 

 

 

Summary of assumptions used to value the warrants

The following table presents the assumptions used to value the warrants:

 

December 31, 2023

 

 

January 2023

Stock price

 

$

0.10

 

 

$0.31 - $0.49

Exercise price

 

$0.47 - $0.50

 

 

$0.47 - $4.50

Expected term

 

4.03-4.24 years

 

 

5 years

Risk-free rate

 

3.90%-3.92%

 

 

3.53%-3.66%

Dividend yield

 

 

 

Volatility

 

129.40%-130.23%

 

 

116.40% - 119.14%

Schedule of fair value of conversion feature liabilities The risk‑free interest rate is based on the implied yield available on U.S. Treasury issues with a term approximating the expected life of the options depending on the date of the grant and expected life of the respective options.

 

 

January 12, 2023

 

Stock price

 

$

0.31

 

Exercise price

 

$

4.50

 

Expected term

 

5-6 years

 

Risk-free rate

 

3.51-3.53%

 

Dividend yield

 

 

Volatility

 

108.16-116.40%